Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 5 | 2024 | 51 | 1.570 |
Why?
|
| Genetic Variation | 5 | 2024 | 1475 | 1.130 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2023 | 458 | 1.110 |
Why?
|
| Genomics | 6 | 2024 | 1473 | 0.910 |
Why?
|
| Genome, Human | 5 | 2022 | 1251 | 0.900 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 3066 | 0.880 |
Why?
|
| Blood Proteins | 1 | 2023 | 117 | 0.860 |
Why?
|
| Biological Evolution | 2 | 2022 | 220 | 0.820 |
Why?
|
| Epilepsy | 2 | 2023 | 852 | 0.800 |
Why?
|
| Transcriptome | 3 | 2024 | 901 | 0.770 |
Why?
|
| Selection, Genetic | 3 | 2022 | 150 | 0.750 |
Why?
|
| Proteomics | 2 | 2024 | 474 | 0.740 |
Why?
|
| Genetic Association Studies | 2 | 2023 | 756 | 0.710 |
Why?
|
| Neurons | 5 | 2024 | 1916 | 0.690 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2022 | 416 | 0.680 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 104 | 0.680 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 126 | 0.660 |
Why?
|
| Schizophrenia | 2 | 2021 | 296 | 0.580 |
Why?
|
| Mutation, Missense | 2 | 2021 | 834 | 0.580 |
Why?
|
| Genetic Testing | 1 | 2024 | 990 | 0.570 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 660 | 0.550 |
Why?
|
| Complement C4 | 1 | 2016 | 5 | 0.530 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 1631 | 0.510 |
Why?
|
| United Kingdom | 6 | 2024 | 189 | 0.490 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2536 | 0.390 |
Why?
|
| Machine Learning | 2 | 2024 | 205 | 0.380 |
Why?
|
| Exome | 3 | 2023 | 1037 | 0.380 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 259 | 0.350 |
Why?
|
| Mutation | 6 | 2023 | 5749 | 0.310 |
Why?
|
| Biomarkers | 3 | 2024 | 2922 | 0.270 |
Why?
|
| Software | 2 | 2022 | 671 | 0.260 |
Why?
|
| Anticonvulsants | 2 | 2020 | 371 | 0.250 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 280 | 0.250 |
Why?
|
| Humans | 24 | 2024 | 121743 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 380 | 0.240 |
Why?
|
| Rhombencephalon | 1 | 2024 | 44 | 0.230 |
Why?
|
| PubMed | 1 | 2023 | 21 | 0.220 |
Why?
|
| Plasma | 1 | 2023 | 96 | 0.210 |
Why?
|
| Telomere | 1 | 2024 | 207 | 0.210 |
Why?
|
| Case-Control Studies | 4 | 2024 | 3221 | 0.210 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2022 | 48 | 0.210 |
Why?
|
| Databases, Genetic | 2 | 2024 | 469 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2022 | 8 | 0.210 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2022 | 7 | 0.210 |
Why?
|
| Cell Lineage | 1 | 2024 | 347 | 0.210 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 248 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2023 | 1138 | 0.200 |
Why?
|
| Hematopoiesis | 1 | 2023 | 218 | 0.190 |
Why?
|
| Phenotype | 5 | 2024 | 4207 | 0.190 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 64 | 0.190 |
Why?
|
| Homozygote | 1 | 2023 | 533 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 2576 | 0.190 |
Why?
|
| Epirizole | 1 | 2020 | 2 | 0.190 |
Why?
|
| Trimipramine | 1 | 2020 | 2 | 0.190 |
Why?
|
| Perphenazine | 1 | 2020 | 6 | 0.190 |
Why?
|
| Trazodone | 1 | 2020 | 7 | 0.190 |
Why?
|
| Carbamazepine | 1 | 2020 | 49 | 0.180 |
Why?
|
| Heterozygote | 1 | 2023 | 679 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 46 | 0.180 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 103 | 0.180 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 312 | 0.180 |
Why?
|
| Codon | 1 | 2020 | 97 | 0.180 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 222 | 0.180 |
Why?
|
| Risperidone | 1 | 2020 | 56 | 0.180 |
Why?
|
| Computational Biology | 3 | 2024 | 793 | 0.170 |
Why?
|
| Disease | 1 | 2021 | 129 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 104 | 0.170 |
Why?
|
| RNA Stability | 1 | 2020 | 85 | 0.170 |
Why?
|
| Cerebellum | 1 | 2023 | 410 | 0.170 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 267 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2020 | 174 | 0.160 |
Why?
|
| Animals | 8 | 2024 | 33670 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2020 | 224 | 0.160 |
Why?
|
| Genotype | 2 | 2023 | 2533 | 0.160 |
Why?
|
| Alleles | 1 | 2023 | 1594 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 191 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 303 | 0.150 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 2677 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 283 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2020 | 605 | 0.150 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 367 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 669 | 0.140 |
Why?
|
| Mice | 6 | 2024 | 17494 | 0.140 |
Why?
|
| Action Potentials | 1 | 2018 | 499 | 0.130 |
Why?
|
| Electrodes, Implanted | 1 | 2015 | 151 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1674 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1199 | 0.100 |
Why?
|
| Aged | 4 | 2024 | 18464 | 0.100 |
Why?
|
| Algorithms | 3 | 2024 | 1573 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 440 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 864 | 0.080 |
Why?
|
| Genetics, Population | 2 | 2022 | 183 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1923 | 0.070 |
Why?
|
| Male | 5 | 2024 | 59138 | 0.060 |
Why?
|
| Female | 5 | 2024 | 64492 | 0.060 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 44 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 134 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 25 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2024 | 225 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 30 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 22 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 194 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2022 | 83 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 58 | 0.050 |
Why?
|
| Cell Division | 1 | 2023 | 796 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 180 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 82 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2021 | 16 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 193 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 145 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 165 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 141 | 0.050 |
Why?
|
| Cell Movement | 1 | 2024 | 846 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2023 | 617 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 578 | 0.040 |
Why?
|
| Lipids | 1 | 2023 | 508 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 743 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 996 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 25388 | 0.040 |
Why?
|
| Microelectrodes | 1 | 2018 | 39 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 874 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1612 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2018 | 270 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2017 | 211 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 692 | 0.030 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 373 | 0.030 |
Why?
|
| Proteins | 1 | 2021 | 1046 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 1758 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 747 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2794 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3069 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 5906 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2082 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3762 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 28623 | 0.010 |
Why?
|